Pot Stocks Soar As DoJ Reclassifies Medical Marijuana As Less Dangerous Drug Pot stocks are moving higher in premarket trading in New York after the Justice Department and DEA announced that FDA-approved marijuana-based drugs and state-licensed medical marijuana products will be moved immediately from Schedule I to Schedule III. This is a major shift in how the federal government classifies these ...
Pot Stocks Soar As DoJ Reclassifies Medical Marijuana As Less Dangerous Drug Pot stocks are moving higher in premarket trading in New York after the Justice Department and DEA announced that FDA-approved marijuana-based drugs and state-licensed medical marijuana products will be moved immediately from Schedule I to Schedule III. This is a major shift in how the federal government classifies these types of cannabis products. *DOJ RECLASSIFIES MEDICAL MARIJUANA AS A LESS-DANGEROUS DRUG: AP — zerohedge (@zerohedge) April 23, 2026 The classification is designed to expand access to approved therapies, support state-regulated medical marijuana programs, and make research easier, while still keeping federal controls in place against black market operators. The reclassification legitimizes medical marijuana programs already operating in 40 states. It also creates a faster DEA registration path for state-licensed medical marijuana operators and protects researchers using state-licensed cannabis products. "The Department of Justice is delivering on President Trump’s promise to expand Americans’ access to medical treatment options," Acting Attorney General Todd Blanche stated in a press release. Blanche continued, “This rescheduling action allows for research on the safety and efficacy of this substance, ultimately providing patients with better care and doctors with more reliable information.” It appears the Trump administration is taking a two-track approach: immediate relief and policy clarity for medical marijuana and researchers, while also setting up a faster legal roadmap toward broader federal reclassification later. The news sent marijuana stocks soaring in premarket trading: Canopy Growth (CGC): $1.48, up about 7% Tilray Brands (TLRY): $8.50, up about 8% Aurora Cannabis (ACB): $4.01, up about 5.5% Cronos Group (CRON): $3, up about 7% Organigram Global (OGI): $1.67, up about 5% SNDL (SNDL): $1.77, up about 6.6% Village Farms (VFF): $3.31, up about 7% Amplify Alternati...
Alison Calazans/iStock Editorial via Getty Images Franklin FTSE Latin America Overview Latin American equities have broken out recently following years of underperforming emerging markets. It appears that momentum should continue in 2026 since these markets are reasonably valued and offer exposure to commodities. Data by YCharts The Franklin FTSE Latin America ETF ( FLLA ) has had favorable perfor...
Alison Calazans/iStock Editorial via Getty Images Franklin FTSE Latin America Overview Latin American equities have broken out recently following years of underperforming emerging markets. It appears that momentum should continue in 2026 since these markets are reasonably valued and offer exposure to commodities. Data by YCharts The Franklin FTSE Latin America ETF ( FLLA ) has had favorable performance since its inception and has outperformed its regional peer, the iShares Latin America 40 ETF ( ILF ). FLLA offers more unique exposure to the market since it has nearly 100 more company holdings, but its country and sector approach is similar to that of ILF. Overall, I think that FLLA is a better way to access Latin America's stock market. Latin America has a series of unique catalysts, including its commodity export growth and supply of key critical minerals. At the moment, these growth drivers should help offset some of the broader macro risks approaching, including a potential rebound of inflation as seen in 2022. FLLA should continue to slightly outperform emerging markets in 2026 and 2027, and looks like a stable hold at the moment. For investors who want to dig deeper, it would be better to invest directly in a basket of country-specific ETFs to increase exposure to Chile and Colombia. Franklin FTSE Latin America ETF Overview The Franklin FTSE Latin America ETF is a smaller ETF ($89 million AUM) that invests in 138 companies in Latin America, primarily in Brazil. It only charges a 0.19% management fee, compared to the 0.47% management fee charged by the iShares Latin America 40 ETF. At the moment, FLLA trades at a circa 24% discount to MSCI Emerging Markets on a price to earnings basis. Franklin Templeton The majority of the companies it covers include mid-cap and large-cap stocks with a market cap above $10 billion. Franklin Templeton This approach has been a superior way to access the market since 2020, as displayed by the divergence in performance between Bra...
Reliance, Inc. ( RS ) declares $1.25/share quarterly dividend , in line with previous. Forward yield 1.43% Payable June 5; for shareholders of record May 22; ex-div May 22. See RS Dividend Scorecard, Yield Chart, & Dividend Growth. More on Reliance, Inc. Reliance, Inc. (RS) Presents at 35th BMO Global Metals, Mining & Critical Minerals Conference Transcript Reliance, Inc. (RS) Q4 2025 Earnings Cal...
Reliance, Inc. ( RS ) declares $1.25/share quarterly dividend , in line with previous. Forward yield 1.43% Payable June 5; for shareholders of record May 22; ex-div May 22. See RS Dividend Scorecard, Yield Chart, & Dividend Growth. More on Reliance, Inc. Reliance, Inc. (RS) Presents at 35th BMO Global Metals, Mining & Critical Minerals Conference Transcript Reliance, Inc. (RS) Q4 2025 Earnings Call Transcript Take Advantage Of The Rotation Into Commodities With Dividend Growth Stock Reliance (Technical Analysis) Reliance tops Q1 estimates as steel demand, pricing lift results Reliance, Inc. Q1 2026 Earnings Preview
(RTTNews) - Expedia Group, Inc. (EXPE), an online travel company, Thursday announced that its Chief Financial Officer, Scott Schenkel is stepping down from his role and will depart from the company on May 16.
(RTTNews) - Expedia Group, Inc. (EXPE), an online travel company, Thursday announced that its Chief Financial Officer, Scott Schenkel is stepping down from his role and will depart from the company on May 16.
jetcityimage/iStock Editorial via Getty Images Following Tesla, Inc.’s ( TSLA ) disappointing Q1 delivery print released earlier this year (the second-worst since 2022), the company has reversed the narrative with better-than-expected earnings results for the quarter. The company grew total revenue by 16% y/y to almost $22.4 billion in Q1, outperforming the average consensus estimate of $22.2 bill...
jetcityimage/iStock Editorial via Getty Images Following Tesla, Inc.’s ( TSLA ) disappointing Q1 delivery print released earlier this year (the second-worst since 2022), the company has reversed the narrative with better-than-expected earnings results for the quarter. The company grew total revenue by 16% y/y to almost $22.4 billion in Q1, outperforming the average consensus estimate of $22.2 billion. Meanwhile, non-GAAP EPS of $0.41 also beat the average market expectation of $0.35. Coupled with a modest capex outlay to kick off the year relative to Tesla’s raised full year investment plan, the company generated positive FCF of $1.4 billion in Q1 – far outpacing the average consensus estimate of a $1.9 billion outflow. While Tesla’s moderating EV sales is evident of its increasingly structural pivot towards an AI- and autonomous-centric roadmap, the company’s latest earnings outperformance continues to support durable FCF accretion from its core business. This continues to represent critical support to the ongoing execution of its capital-intensive ambitions ahead – especially as Tesla eyes capex spend of $25 billion this year, which is higher than previous expectations benchmarked at $20 billion. The stock’s pullback this year also meaningfully de-risks against ongoing pressure in auto sales, making room for renewed upside as visibility into its longer-term AI and autonomy roadmap improves. Specifically, the stock’s current price at about $388 per share approximates my previous price target, which accounts primarily for Tesla’s operations that’ve shown tangible fundamental visibility. However, its latest earnings update positions Tesla for further upside as visibility into longer-term Robotaxi and Optimus monetization improves. In the following analysis, I provide an updated sum-of-the-parts (“SOTP”) analysis for each of Tesla’s existing auto, energy generation and storage (“EGS”) and full self-drive ("FSD") businesses, while also incorporating an incremental valu...
jetcityimage/iStock Editorial via Getty Images Following Tesla, Inc.’s ( TSLA ) disappointing Q1 delivery print released earlier this year (the second-worst since 2022), the company has reversed the narrative with better-than-expected earnings results for the quarter. The company grew total revenue by 16% y/y to almost $22.4 billion in Q1, outperforming the average consensus estimate of $22.2 bill...
jetcityimage/iStock Editorial via Getty Images Following Tesla, Inc.’s ( TSLA ) disappointing Q1 delivery print released earlier this year (the second-worst since 2022), the company has reversed the narrative with better-than-expected earnings results for the quarter. The company grew total revenue by 16% y/y to almost $22.4 billion in Q1, outperforming the average consensus estimate of $22.2 billion. Meanwhile, non-GAAP EPS of $0.41 also beat the average market expectation of $0.35. Coupled with a modest capex outlay to kick off the year relative to Tesla’s raised full year investment plan, the company generated positive FCF of $1.4 billion in Q1 – far outpacing the average consensus estimate of a $1.9 billion outflow. While Tesla’s moderating EV sales is evident of its increasingly structural pivot towards an AI- and autonomous-centric roadmap, the company’s latest earnings outperformance continues to support durable FCF accretion from its core business. This continues to represent critical support to the ongoing execution of its capital-intensive ambitions ahead – especially as Tesla eyes capex spend of $25 billion this year, which is higher than previous expectations benchmarked at $20 billion. The stock’s pullback this year also meaningfully de-risks against ongoing pressure in auto sales, making room for renewed upside as visibility into its longer-term AI and autonomy roadmap improves. Specifically, the stock’s current price at about $388 per share approximates my previous price target, which accounts primarily for Tesla’s operations that’ve shown tangible fundamental visibility. However, its latest earnings update positions Tesla for further upside as visibility into longer-term Robotaxi and Optimus monetization improves. In the following analysis, I provide an updated sum-of-the-parts (“SOTP”) analysis for each of Tesla’s existing auto, energy generation and storage (“EGS”) and full self-drive ("FSD") businesses, while also incorporating an incremental valu...
(RTTNews) - Heartland Express, Inc. (HTLD) reported Thursday a net loss for the first quarter that narrowed to $4.82 million or $0.06 per share from $13.87 million or $0.18 per share in the prior-year quarter.
(RTTNews) - Heartland Express, Inc. (HTLD) reported Thursday a net loss for the first quarter that narrowed to $4.82 million or $0.06 per share from $13.87 million or $0.18 per share in the prior-year quarter.
Univest Financial ( UVSP ) declares $0.23/share quarterly dividend , 4.5% increase from prior dividend of $0.22. Forward yield 2.5% Payable May 20; for shareholders of record May 6; ex-div May 6. See UVSP Dividend Scorecard, Yield Chart, & Dividend Growth. More on Univest Financial Univest Financial Corporation (UVSP) Q4 2025 Earnings Call Transcript Univest targets 4%–6% net interest income growt...
Univest Financial ( UVSP ) declares $0.23/share quarterly dividend , 4.5% increase from prior dividend of $0.22. Forward yield 2.5% Payable May 20; for shareholders of record May 6; ex-div May 6. See UVSP Dividend Scorecard, Yield Chart, & Dividend Growth. More on Univest Financial Univest Financial Corporation (UVSP) Q4 2025 Earnings Call Transcript Univest targets 4%–6% net interest income growth in 2026 while expanding share repurchase plan Univest Financial GAAP EPS of $0.79 beats by $0.02, revenue of $84.57M beats by $2.03M Seeking Alpha’s Quant Rating on Univest Financial Historical earnings data for Univest Financial